MX2015015178A - Metodos para potenciar la regeneracion de musculos envejecidos. - Google Patents

Metodos para potenciar la regeneracion de musculos envejecidos.

Info

Publication number
MX2015015178A
MX2015015178A MX2015015178A MX2015015178A MX2015015178A MX 2015015178 A MX2015015178 A MX 2015015178A MX 2015015178 A MX2015015178 A MX 2015015178A MX 2015015178 A MX2015015178 A MX 2015015178A MX 2015015178 A MX2015015178 A MX 2015015178A
Authority
MX
Mexico
Prior art keywords
methods
enhancing
muscle regeneration
aged muscle
beta
Prior art date
Application number
MX2015015178A
Other languages
English (en)
Spanish (es)
Inventor
Sean Garvey
Suzette Pereira
Neile Edens
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2015015178A publication Critical patent/MX2015015178A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2015015178A 2013-05-01 2014-05-01 Metodos para potenciar la regeneracion de musculos envejecidos. MX2015015178A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361818237P 2013-05-01 2013-05-01
PCT/US2014/036297 WO2014179526A1 (en) 2013-05-01 2014-05-01 Methods for enhancing aged muscle regeneration

Publications (1)

Publication Number Publication Date
MX2015015178A true MX2015015178A (es) 2016-02-26

Family

ID=50885012

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015178A MX2015015178A (es) 2013-05-01 2014-05-01 Metodos para potenciar la regeneracion de musculos envejecidos.

Country Status (11)

Country Link
US (1) US20160066610A1 (https=)
EP (1) EP2999359A1 (https=)
JP (1) JP2016520050A (https=)
CN (1) CN105188413A (https=)
BR (1) BR112015027563A2 (https=)
CA (1) CA2911471A1 (https=)
HK (1) HK1221609A1 (https=)
MX (1) MX2015015178A (https=)
PH (1) PH12015502319A1 (https=)
SG (1) SG11201508388YA (https=)
WO (1) WO2014179526A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015094772A1 (en) * 2013-12-18 2015-06-25 Abbott Laboratories Methods for increasing skeletal muscle protein synthesis using green tea extract
WO2016044272A1 (en) * 2014-09-16 2016-03-24 Abbott Laboratories Methods of preserving muscle strength during a period of muscle disuse by administering beta-hydroxy-beta-methylbutyrate and green tea extract
JP6664956B2 (ja) * 2015-02-27 2020-03-13 キリンホールディングス株式会社 筋分化促進組成物
ES2806684T3 (es) * 2015-09-16 2021-02-18 Abbott Lab Composición nutricional líquida, de larga duración y reducida en grasas
AU2017207910B2 (en) * 2016-01-13 2022-09-01 Metabolic Technologies, Inc. Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for joint stability
WO2017168006A1 (en) * 2016-04-01 2017-10-05 Dsm Ip Assets B.V. Beverages comprising stable granules of milled lutein
CN121177244A (zh) 2016-05-25 2025-12-23 技源集团股份有限公司 包含3-羟基-3-甲基丁酸的软凝胶胶囊剂
WO2018027070A1 (en) * 2016-08-04 2018-02-08 Seattle Gummy Company Compositions for athletic performance and methods of making and using thereof
WO2018027081A1 (en) * 2016-08-04 2018-02-08 Seattle Gummy Company Health management compositions and methods of making and using thereof
US20210368843A1 (en) * 2016-08-04 2021-12-02 Seattle Gummy Company Mineral compositions and methods of making and using thereof
US12370159B2 (en) 2016-10-21 2025-07-29 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics
WO2018075867A1 (en) * 2016-10-21 2018-04-26 Metabolic Technologies, Inc. COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) AND PROBIOTICS
MX2019014595A (es) 2017-06-09 2020-02-05 Philip Morris Products Sa Articulo generador de aerosol que tiene un segmento de filtro fibroso.
US20190037904A1 (en) * 2017-08-04 2019-02-07 Sean R. Daly Food-based protein formulation
JP7368364B2 (ja) 2018-02-09 2023-10-24 トプソー・アクチエゼルスカベット α-ヒドロキシ化合物の製造方法およびその使用
WO2019246395A1 (en) * 2018-06-23 2019-12-26 Seattle Gummy Company Methods and compositions for reducing caffeine side effects
JP6541047B1 (ja) * 2018-10-18 2019-07-10 株式会社東洋新薬 経口組成物
JP2023517997A (ja) * 2020-03-10 2023-04-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 負荷誘発性筋肥大を増強するための新規栄養素
WO2021236440A1 (en) 2020-05-20 2021-11-25 Advanced Food Concepts, Inc. Athletic performance enhancement composition using menthol
CN112568444A (zh) * 2020-11-20 2021-03-30 格乐瑞(无锡)营养科技有限公司 一种缓解肌肉流失的组合物及其制备方法
WO2023190293A1 (ja) * 2022-03-30 2023-10-05 ニュートリー株式会社 とろみ状栄養組成物
WO2025030001A2 (en) * 2023-08-02 2025-02-06 Abbott Laboratories Methods and compositions for maintaining skeletal muscle mobility and/or mass, and/or for recovery of skeletal muscle strength
KR20250168792A (ko) * 2024-05-24 2025-12-02 주식회사 메타매스 프로바이오틱스 대사체를 유효성분으로 포함하는 근육질환의 예방 또는 치료용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
RU2414897C2 (ru) * 2005-11-30 2011-03-27 Нестек С.А. Способы лечения потери мышечной массы
EP2025346B1 (en) * 2006-04-07 2016-08-10 Osaka University Muscle regeneration promoter
JP5507802B2 (ja) * 2006-08-10 2014-05-28 花王株式会社 筋肉老化抑制剤
JP2012533627A (ja) * 2009-07-20 2012-12-27 ネステク ソシエテ アノニム 機能状態の喪失を減弱する方法
CA2821312A1 (en) * 2010-12-27 2012-07-05 Abbott Laboratories Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
WO2012097064A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism

Also Published As

Publication number Publication date
WO2014179526A1 (en) 2014-11-06
PH12015502319A1 (en) 2016-02-10
BR112015027563A2 (pt) 2017-07-25
EP2999359A1 (en) 2016-03-30
HK1221609A1 (zh) 2017-06-09
JP2016520050A (ja) 2016-07-11
CN105188413A (zh) 2015-12-23
US20160066610A1 (en) 2016-03-10
CA2911471A1 (en) 2014-11-06
SG11201508388YA (en) 2015-11-27

Similar Documents

Publication Publication Date Title
PH12015502319A1 (en) Methods for enhancing aged muscle regeneration
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
MX2014010455A (es) Metodos y composiciones para tratar enfermedad de huntington.
PH12015501354A1 (en) Antiviral compounds
UY34804A (es) Inhibidores del nampt
UY34697A (es) Métodos para preparar análogos de nucleótidos
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
MX2015010921A (es) Compuestos de carbazol utiles como inhibidores de bromodominio.
PH12015502167A1 (en) Methods of maintaining and improving muscle function
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
ZA201707183B (en) Regenerative railway braking system
MX2015015593A (es) Placa de osteosintesis y sistema para osteosintesis.
UA117032C2 (uk) Селективний інгібітор фосфатидилінозитол-3-кінази-гамма
SG11201502649WA (en) Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
MY173521A (en) Trpv4 antagonists
MX2014015390A (es) Metodos para la desolventizacion de bagazo.
EP2989123A4 (en) METHODS AND COMPOSITIONS FOR TREATING COAGULATION DISORDERS
WO2014091167A3 (fr) Composes cyclopropylboroniques, leur procede de preparation et leur utilisation
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
WO2015011669A3 (en) Phenolic compounds as end-capping agents for polysiloxanes in polycarbonate-polysiloxane block copolymers
IN2014DN08412A (https=)
SG11201500918YA (en) Method, combination and/or composition for inducing cardiomyocyte differentation
IN2014DN09584A (https=)
PH12015501281A1 (en) Use of methyl mercapto-esters as chain transfer agents